Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006509Source: DataRank Database

Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model is a research paper published in Journal for ImmunoTherapy of Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)OA: goldTopics (32)IDs (PubMed, PMC)Annotations (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Preeti Sharma ORCID,Claire P. Schane ORCID,Amber N Lewis ORCID,Edward F. Valdez,Venkata V.V.R. Marada ORCID

Live enrichment

PubMed:37258040 PMC:PMC10255004

Gerald O. Mann Foundation

Grant: N/A

NIH

Grant: CA022677

NIH

Grant: CA120439

NIH

Grant: CA238628

NIH

Grant: CA256746

NCI NIH HHS

Grant: R01 CA120439

NCI NIH HHS

Grant: R01 CA022677

NCI NIH HHS

Grant: R21 CA238628

National Institutes of Health

Grant: 5R21CA238628-02

Engineering CARs against cancer-specific glycoproteins

National Institutes of Health

Grant: 4R01CA120439-09

Small Molecule Activators of Procaspases as Anti-Cancer Agents

goldLicense: cc-by-nc

publisherhttps://jitc.bmj.com/content/jitc/11/5/e006509.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2022-006509

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10255004/pdf/jitc-2022-006509.pdf

repositoryhttps://doaj.org/article/861817e037174ed8a392e07d910f8aaf

Europe_PMChttps://europepmc.org/articles/PMC10255004

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

T-LymphocytesAnimalsMice, Inbred C57BLHumansMiceOvarian NeoplasmsCytokinesImmunotherapy, AdoptiveXenograft Model Antitumor AssaysFemaleTumor MicroenvironmentReceptors, Chimeric Antigen

Keywords

Cell engineeringImmunotherapyT-lymphocytesAntigens, Tumor-associated, CarbohydrateReceptors, Chimeric AntigenOvarian NeoplasmsImmune Cell Therapies and Immune Cell EngineeringNeoplasms. Tumors. Oncology. Including cancer and carcinogensImmunotherapy, AdoptiveXenograft Model Antitumor AssaysMice, Inbred C57BLMiceTumor MicroenvironmentHumansAnimalsCytokinesFemaleRC254-282

Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model

FAIR Checklist

Authors (16)

Funding (10 grants)

Open Access

Topics

Annotations (Europe PMC)